1 – 10 of 1890
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
- Extracorporeal Membrane Oxygenation Support in Children with Hematological Malignancies in Sweden
-
Human radical scavenger α1-microglobulin protects against hemolysis in vitro and α1-microglobulin knockout mice exhibit a macrocytic anemia phenotype
Kristiansson, Amanda LU ; Bergwik, Jesper LU ; Alattar, Abdul Ghani LU
; Flygare, Johan
LU
; Gram, Magnus
LU
; Hansson, Stefan R
LU
; Olsson, Martin L
LU
; Storry, Jill R
LU
; Allhorn, Maria
LU
and Åkerström, Bo
LU
(2021)
In Free Radical Biology & Medicine
162.
Mark
- Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B : a PedNet study
- Successful tyrosine kinase inhibitor discontinuation outside clinical trials — data from the population-based Swedish chronic myeloid leukaemia registry
- Measurable residual disease and clonal evolution in acute myeloid leukemia with focus on NPM1-mutations
- Burkitt Lymphoma International Prognostic Index
-
Ontogenic shifts in cellular fate are linked to proteotype changes in lineage-biased hematopoietic progenitor cells
Jassinskaja, Maria LU ; Pimková, Kristýna LU ; Arh, Nejc LU ; Johansson, Emil LU
; Davoudi, Mina
LU
; Pereira, Carlos Filipe
LU
; Sitnicka, Ewa
LU
and Hansson, Jenny
LU
(2021)
In Cell Reports
34(12).
Mark
-
Treatment outcomes in persons with severe haemophilia B in the Nordic region : The B-NORD study
Kihlberg, Kristina LU ; Baghaei, Fariba ; Bruzelius, Maria ; Funding, Eva LU ; Andre Holme, Pål ; Lassila, Riitta ; Nummi, Vuokko LU ; Ranta, Susanna ; Osooli, Mehdi LU
and Berntorp, Erik
LU
, et al.
(2021)
In Haemophilia
Mark
- Detailed Long-Term Follow-Up of Patients Who Relapsed after the Nordic Mantle Cell Lymphoma Trials : MCL2 and MCL3
- Validation of factor VIII activity for monitoring standard and extended half-life products and correlation to thrombin generation assays